Clinical Utility of Measuring Infliximab (IFX) and Adalimumab (ADA) and Anti-drug Antibody Levels Using the LabCorp Assay in Patients With Inflammatory Bowel Disease (IBD): 735Brown, SaraPerinbasekar, RajivSyed, NaurozLonsako, ShumetCross, Raymond...
The PhenoSense Monoclonal Antibody Assay (Labcorp-Monogram Biosciences) is a phenotypic cell-based infectivity assay capable of assessing the susceptibility of pseudovirions bearing plasma or PMBC-derived HIV-1 envelope proteins to anti-envelope monoclonal antibodies. Populations of full-length envelope s...
combination therapy29. To address the shortcomings of current therapeutic strategies targeting CD137, we undertook an unbiased functional screening approach that identified a full-length bispecific antibody (bAb) that potently activates CD137 via engagement of PD-L1 to enhance tumor-specific T cell ...
millipore MRCF0R100ET Consumables MicroconDNAFastFlowPCRGradeDualcycleEtOt PK 926.00 millipore MRCPRT010 Consumables Protein Microcon - 10 KDa - 100 pk PK 4,200.00 millipore MRCPRTLCA Consumables Microcon 10K 500pk LabCorp EA 6,130.00 millipore MSABI9602 Consumables ABI Rec. Plate Adapter-MScn...
The PhenoSense Monoclonal Antibody Assay (Labcorp-Monogram Biosciences) is a phenotypic cell-based infectivity assay capable of assessing the susceptibility of pseudovirions bearing plasma or PMBC-derived HIV-1 envelope proteins to anti-envelope monoclonal antibodies. Populations of full-length envelope ...